Skip to main content

The Coagulation Cascade and its Therapeutic Modulation

  • Chapter
  • First Online:
Book cover Heart of the Matter

Part of the book series: Learning Materials in Biosciences ((LMB))

  • 1075 Accesses

Abstract

This chapter will provide a comprehensive overview of both primary and secondary haemostasis at a gross and molecular level, in addition to examining the relevant signalling and cellular mediators of these dual processes. We will then discuss three key regulatory mechanisms, whilst simultaneously exploring the clinical relevance of both the aforementioned mechanisms and the aberrance of coagulation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 79.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 99.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Versteeg HH et al (2013) New fundamentals in hemostasis. Physiol Rev 93:327. https://www.physiology.org/doi/full/10.1152/physrev.00016.2011

    Article  CAS  Google Scholar 

  2. Broos K et al (2011) Platelets at work in primary hemostasis. Blood Rev 25(4):155–167. https://doi.org/10.1016/j.blre.2011.03.002

    Article  CAS  PubMed  Google Scholar 

  3. Peyvandi F et al (2011) Role of von Willebrand factor in the haemostasis. Blood Transfus 9(Suppl 2):s3–s8. https://doi.org/10.2450/2011.002S

    Article  PubMed  PubMed Central  Google Scholar 

  4. Gale AJ (2011) Current understanding of hemostasis. Toxicol Pathol 39(1):273–280. https://doi.org/10.1177/0192623310389474

    Article  PubMed  Google Scholar 

  5. Seong-Hoon Y et al (2016) Platelet activation: the mechanisms and potential biomarkers. Biomed Res Int 2016:1. https://doi.org/10.1155/2016/9060143

    Article  CAS  Google Scholar 

  6. Blair P et al (2009) Platelet a-granules: basic biology and clinical correlates. Blood Rev 23(4):177–189. https://doi.org/10.1016/j.blre.2009.04.001

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Hanby HA et al (2017) Platelet dense granules begin to selectively accumulate mepacrine during proplatelet formation. Blood Adv 1(19):1478–1490. https://doi.org/10.1182/bloodadvances.2017006726

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Behan MWH, Storey RF (2004) Antiplatelet therapy in cardiovascular disease. Postgrad Med J 80:155–164. https://doi.org/10.1136/pgmj.2003

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Bhatt DL, Topol EJ (2003) Scientific and therapeutic advances in antiplatelet therapy. Nat Rev Drug Discov 2(1):15–29. https://doi.org/10.1038/nrd985

    Article  CAS  PubMed  Google Scholar 

  10. Savi P et al (1998) Clopidogrel: a review of its mechanism of action. Platelets 9(3–4):251–255. https://doi.org/10.1080/09537109876799

    Article  CAS  PubMed  Google Scholar 

  11. Chatterjee S et al (2013) PAR-1 antagonists: current state of evidence. J Thromb Thrombolysis 35(1):1–9. https://doi.org/10.1007/s11239-012-0752-4

    Article  CAS  PubMed  Google Scholar 

  12. Horiuchi H (2006) Recent advance in antiplatelet therapy: the mechanisms, evidence and approach to problems. Ann Med 38(3):162–172. https://doi.org/10.1080/07853890600640657

    Article  CAS  PubMed  Google Scholar 

  13. Wang TH et al (2006) Aspiring and clopidogrel resistance: an emerging clinical entity. Eur Heart J 27(6):647–654. https://doi.org/10.1093/eurheartj/ehi684

    Article  CAS  PubMed  Google Scholar 

  14. Pozzi N et al (2013) Autoactivation of thrombin precursors. J Biol Chem 288(16):11601–11610. https://doi.org/10.1074/jbc.M113.451542

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Lenting PJ et al (1998) The life cycle of coagulation factor VIII in view of its structure and function. Blood 92:3983–3996

    Article  CAS  Google Scholar 

  16. Geddings JE (2014) New players in haemostasis and thrombosis. Thromb Haemost 111(4):570–574. https://doi.org/10.1160/TH13-10-0812

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. Crawley JTB, Lane DA (2008) The haemostatic role of tissue factor pathway inhibitor. Arterioscler Thromb Vasc Biol 28(2):233–242. https://doi.org/10.1161/ATVBAHA.107.141606

    Article  CAS  PubMed  Google Scholar 

  18. Wood et al (2014) Biology of tissue factor pathway inhibitor. Blood 123(19):2934–2943. https://doi.org/10.1182/blood-2013-11-512764

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Castoldi E, Hackeng TM (2008) Regulation of coagulation by protein S. Curr Opin Haematol 15(5):529–536. https://doi.org/10.1097/MOH.0b013e328309ec97

    Article  CAS  Google Scholar 

  20. Kalafatis M, Rand MD, Mann KG (1994) The mechanism of inactivation of human factor V and human factor Va by activated protein C. J Biol Chem 269(50):31869–31880

    CAS  PubMed  Google Scholar 

  21. Rosenberg RD, Damus PS (1973) The purification and mechanism of action of human antithrombin-heparin cofactor. J Biol Chem 248(18):6490–6505

    CAS  PubMed  Google Scholar 

  22. Lim GB (2015) Anticoagulants. Nat Rev Cardiol. https://doi.org/10.1038/nrcardio.2017.170

  23. Hirsh J et al (2003) American Heart Association/American College of Cardiology Foundation guide to warfarin therapy. Circulation 107:1692–1711

    Article  Google Scholar 

  24. Hirsh J et al (2001) Heparin and low-molecular-weight heparin mechanisms of action, pharmacokinetics, dosing, monitoring, efficacy and safety. Chest J 119(1):64S–94S. doi: 0.1378/chest.119.1_suppl.64S

    Article  CAS  Google Scholar 

  25. Basu D et al (1972) A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. NEJM 287:324–327. https://doi.org/10.1056/NEJM197208172870703

    Article  CAS  PubMed  Google Scholar 

  26. Salzman EW et al (1975) Management of heparin therapy – controlled prospective trial. NEJM 292:1046–1050. https://doi.org/10.1056/NEJM197505152922002

  27. Pollack CV Jr (2016) Coagulation assessment with the new generation of oral anticoagulants. BMJ 33(6):423–430

    Google Scholar 

  28. Wilson MR, Docherty KF, Gardner RS (2016) Use of direct oral anticoagulants in thromboembolic disease. Prescriber Drug Rev 27(8):15. https://doi.org/10.1002/psb.1487

    Article  Google Scholar 

  29. Garcia D, Libby E, Crowther MA (2010) The new oral anticoagulants. Blood 115(1):15–20. https://doi.org/10.1182/blood-2009-09-241851

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to James Crawley .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Thielemans, L., Hanif, M., Crawley, J. (2019). The Coagulation Cascade and its Therapeutic Modulation. In: Terracciano, C., Guymer, S. (eds) Heart of the Matter. Learning Materials in Biosciences. Springer, Cham. https://doi.org/10.1007/978-3-030-24219-0_16

Download citation

Publish with us

Policies and ethics